BioCentury | Feb 25, 2020
Product Development

Singapore deploys antibody testing for COVID-19

...Singapore MOH reported that antibody testing confirmed that a COVID-19 cluster at a church, the Grace...
BioCentury | Jan 10, 2020
Company News

Lilly bolsters atopic dermatitis arsenal via $1.1B Dermira deal, gaining Dupixent challenger

...66% in a day (see “Dermira Plummets After Phase III Acne Failure” ). Dermira’s saving grace...
BioCentury | Oct 18, 2019
Targets & Mechanisms

How glycoRNA could go from surprise discovery to therapeutic target

...Stanford University and cofounder of two therapeutics companies targeting protein glycobiology: Palleon Pharmaceuticals Inc. and Grace...
BioCentury | Oct 16, 2019
Financial News

Woodford shutters firm, third fund

...Neil Woodford’s fall from grace reached its end Tuesday night when the former star fund manager...
BioCentury | Oct 15, 2019
Financial News

Woodford flagship fund implodes as star fund manager axed

...Ltd., which was the WEIF’s fourth-largest healthcare holding at April 30. Despite Woodford’s fall from grace...
BioCentury | Sep 14, 2019
Finance

Mark Schoenebaum: Setting the gold standard

...in the world for you, his punishing schedule notwithstanding. He was a model of humility, grace...
BioCentury | Aug 16, 2019
Emerging Company Profile

Grace: seeking cures in pathological roots

...Grace Science LLC’s origins stem from the diagnosis of co-founder and CEO Matt Wilsey’s daughter Grace...
...NASDAQ:BMRN), San Rafael, Calif. Glycomine Inc., San Carlos, Calif. Grace Science Foundation, Menlo Park, Calif. Grace...
...N-glycanase 1 (NGLY1) NFE2L2 (NRF2) - Nuclear factor (erythroid-derived 2)-like 2 Sandi Wong, Staff Writer Grace Science Foundation Grace...
BioCentury | Feb 15, 2019
Financial News

CStone could get $1.5B valuation in Hong Kong IPO

CStone Pharmaceuticals Co. Ltd. (Suzhou, China) would be valued at HK$11.8 billion ($1.5 billion) if it prices its Hong Kong IPO at the midpoint of its proposed range. The cancer company plans to sell 186.4...
BioCentury | Feb 14, 2019
Financial News

CStone could get $1.5B valuation in Hong Kong IPO

CStone Pharmaceuticals Co. Ltd. (Suzhou, China) would be valued at HK$11.8 billion ($1.5 billion) if it prices its Hong Kong IPO at the midpoint of its proposed range. The cancer company plans to sell 186.4...
BioCentury | Jan 3, 2019
Distillery Therapeutics

Cancer

...DETAILS: Sun, H. et al. Nat. Commun. ; published online December 6, 2018 doi:10.1038/s41467-018-07402-8 CONTACT: Grace...
Items per page:
1 - 10 of 105
BioCentury | Feb 25, 2020
Product Development

Singapore deploys antibody testing for COVID-19

...Singapore MOH reported that antibody testing confirmed that a COVID-19 cluster at a church, the Grace...
BioCentury | Jan 10, 2020
Company News

Lilly bolsters atopic dermatitis arsenal via $1.1B Dermira deal, gaining Dupixent challenger

...66% in a day (see “Dermira Plummets After Phase III Acne Failure” ). Dermira’s saving grace...
BioCentury | Oct 18, 2019
Targets & Mechanisms

How glycoRNA could go from surprise discovery to therapeutic target

...Stanford University and cofounder of two therapeutics companies targeting protein glycobiology: Palleon Pharmaceuticals Inc. and Grace...
BioCentury | Oct 16, 2019
Financial News

Woodford shutters firm, third fund

...Neil Woodford’s fall from grace reached its end Tuesday night when the former star fund manager...
BioCentury | Oct 15, 2019
Financial News

Woodford flagship fund implodes as star fund manager axed

...Ltd., which was the WEIF’s fourth-largest healthcare holding at April 30. Despite Woodford’s fall from grace...
BioCentury | Sep 14, 2019
Finance

Mark Schoenebaum: Setting the gold standard

...in the world for you, his punishing schedule notwithstanding. He was a model of humility, grace...
BioCentury | Aug 16, 2019
Emerging Company Profile

Grace: seeking cures in pathological roots

...Grace Science LLC’s origins stem from the diagnosis of co-founder and CEO Matt Wilsey’s daughter Grace...
...NASDAQ:BMRN), San Rafael, Calif. Glycomine Inc., San Carlos, Calif. Grace Science Foundation, Menlo Park, Calif. Grace...
...N-glycanase 1 (NGLY1) NFE2L2 (NRF2) - Nuclear factor (erythroid-derived 2)-like 2 Sandi Wong, Staff Writer Grace Science Foundation Grace...
BioCentury | Feb 15, 2019
Financial News

CStone could get $1.5B valuation in Hong Kong IPO

CStone Pharmaceuticals Co. Ltd. (Suzhou, China) would be valued at HK$11.8 billion ($1.5 billion) if it prices its Hong Kong IPO at the midpoint of its proposed range. The cancer company plans to sell 186.4...
BioCentury | Feb 14, 2019
Financial News

CStone could get $1.5B valuation in Hong Kong IPO

CStone Pharmaceuticals Co. Ltd. (Suzhou, China) would be valued at HK$11.8 billion ($1.5 billion) if it prices its Hong Kong IPO at the midpoint of its proposed range. The cancer company plans to sell 186.4...
BioCentury | Jan 3, 2019
Distillery Therapeutics

Cancer

...DETAILS: Sun, H. et al. Nat. Commun. ; published online December 6, 2018 doi:10.1038/s41467-018-07402-8 CONTACT: Grace...
Items per page:
1 - 10 of 105